Fidelis Care is pleased to inform you that the most recent 2019 QARR Non-Compliance Report has been posted on Provider Access Online (provider portal). This information is indicative of all encounter data on file with Fidelis Care as of 04/15/2019.
Attention! Due to a scheduled system upgrade, Provider Access Online (provider portal) will be “read only” from Friday, June 7 at 6PM through Sunday, June 9, 2019.
The following sections of the Fidelis Care authorization grids have been updated effective July 1, 2019. The following services apply to Medicaid, Child Health Plus, and HealthierLife (HARP) lines of business and require prior authorization: IV. Behavioral Health – Outpatient services:
Providers, please remember to review content available in Provider Access Online (Fidelis Care’s secure Provider Portal) and the rest of this Provider section of the Fidelis Care website. Both locations are excellent resources of information about our programs and services.
Fidelis Care can help you fight opioid misuse. More people are dying of opioid overdoses than ever before in New York State. According to the State Department of Health, more than 3,000 individuals died of an opioid overdose in 2016. Buprenorphine is the first at-home medication therapy proven to be clinically effective against opioid use disorder (OUD). Buprenorphine can be an essential tool for helping you treat your OUD patients.